diaziquone has been researched along with Breast Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedikian, AY; Blumenschein, GR; Bodey, GP; Schell, FC; Yap, HY | 1 |
| Gutierrez, PL; Ngo, EO; Nutter, LM; Sura, T | 1 |
| Fisher, GR; Gutierrez, PL | 1 |
| Dicke, KA; Spitzer, G | 1 |
| Haas, C; Martino, S; Ratanatharathorn, V; Samal, BA; Singhakowinta, A | 1 |
1 review(s) available for diaziquone and Breast Neoplasms
| Article | Year |
|---|---|
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous | 1986 |
4 other study(ies) available for diaziquone and Breast Neoplasms
| Article | Year |
|---|---|
Phase II clinical evaluation of AZQ in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Blood Cell Count; Breast Neoplasms; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis | 1983 |
Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Benzoquinones; Breast Neoplasms; Humans; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Breast Neoplasms; Cell-Free System; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Oxygen Consumption; Quinone Reductases; Substrate Specificity; Tumor Cells, Cultured | 1991 |
Treatment of metastatic breast cancer with AZQ: a phase II trial.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Breast Neoplasms; Drug Evaluation; Humans; Middle Aged; Neoplasm Metastasis | 1988 |